{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:48:18Z","timestamp":1789202898022,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001249","name":"University of Tasmania","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001249","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["352611"],"award-info":[{"award-number":["352611"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.gene.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T12:49:07Z","timestamp":1538570947000},"page":"12-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Mutations in the HFE gene can be associated with increased lung disease severity in cystic fibrosis"],"prefix":"10.1016","volume":"683","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8945-1531","authenticated-orcid":false,"given":"Daniel J.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerenaftali","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"Hartel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Wainwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gene.2018.10.002_bb0005","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/carcin\/bgt045","article-title":"Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the European prospective investigation into cancer and nutrition (EPIC) study","volume":"34","author":"Agudo","year":"2013","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.gene.2018.10.002_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1530\/EJE-13-0145","article-title":"Body iron stores and the risk of type 2 diabetes in middle-aged men","volume":"169","author":"Aregbesola","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.gene.2018.10.002_bb0015","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jama.2009.1295","article-title":"Genetic modifiers of liver disease in cystic fibrosis","volume":"302","author":"Bartlett","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.gene.2018.10.002_bb0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MAJ.0000000000000192","article-title":"Hemochromatosis and iron overload: from bench to clinic","volume":"346","author":"Barton","year":"2013","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.gene.2018.10.002_bb0025","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s00125-009-1436-2","article-title":"A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis","volume":"52","author":"Blackman","year":"2009","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.gene.2018.10.002_bb0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1513\/pats.200605-129JG","article-title":"Strategies for identifying modifier genes in cystic fibrosis","volume":"4","author":"Boyle","year":"2007","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"7","key":"10.1016\/j.gene.2018.10.002_bb0035","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1046\/j.1440-1746.2002.02792.x","article-title":"Genetic testing for HFE hemochromatosis in Australia: the value of testing relatives of simple heterozygotes","volume":"17","author":"Cavanaugh","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"Suppl. 2","key":"10.1016\/j.gene.2018.10.002_bb0040","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1569-1993(11)60005-2","article-title":"Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients","volume":"10","author":"Colombo","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.gene.2018.10.002_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2350-8-69","article-title":"Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay","volume":"8","author":"Cukjati","year":"2007","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.gene.2018.10.002_bb0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.2010.05879.x","article-title":"Modifier genes in Mendelian disorders: the example of cystic fibrosis","volume":"1214","author":"Cutting","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.gene.2018.10.002_bb0055","series-title":"Annual Data Report. Bethesda","first-page":"2012","author":"Cystic Fibrosis Foundation patient Registry","year":"2010"},{"key":"10.1016\/j.gene.2018.10.002_bb0060","series-title":"Cystic Fibrosis in Australia 2012: 15th Annual report Australian Cystic Fibrosis Data Registry. Baulkham Hills, NSW, Australia","year":"2013"},{"issue":"2","key":"10.1016\/j.gene.2018.10.002_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/109065703322146876","article-title":"HFE alleles in an Irish cystic fibrosis population","volume":"7","author":"Devaney","year":"2003","journal-title":"Genet. Test."},{"issue":"3","key":"10.1016\/j.gene.2018.10.002_bb0070","first-page":"1040","article-title":"Complex two-gene modulation of lung disease severity in children with cystic fibrosis","volume":"118","author":"Dorfman","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"14","key":"10.1016\/j.gene.2018.10.002_bb0075","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMoa051469","article-title":"Genetic modifiers of lung disease in cystic fibrosis","volume":"353","author":"Drumm","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.gene.2018.10.002_bb0080","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/hep.21885","article-title":"Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls","volume":"46","author":"Ellervik","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gene.2018.10.002_bb0085","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2337\/dc13-1198","article-title":"Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes: two general population studies","volume":"37","author":"Ellervik","year":"2014","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.gene.2018.10.002_bb0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr. Pulmonol."},{"issue":"Suppl","key":"10.1016\/j.gene.2018.10.002_bb0095","first-page":"A171","article-title":"A semi-automated method for the measurement of hepcidin in plasma by on-line extraction coupled to liquid chromatography-tandem mass spectrometry","volume":"57","author":"Franklin","year":"2010","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.gene.2018.10.002_bb0100","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1002\/ijc.25577","article-title":"Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis","volume":"128","author":"Gannon","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.gene.2018.10.002_bb0105","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00109-003-0493-0","article-title":"Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype","volume":"81","author":"Gehrke","year":"2003","journal-title":"J. Mol. Med."},{"issue":"2","key":"10.1016\/j.gene.2018.10.002_bb0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrg3118","article-title":"Rare and common variants: twenty arguments","volume":"13","author":"Gibson","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.gene.2018.10.002_bb0115","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0022-3476(89)80134-9","article-title":"Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus","volume":"114","author":"Kerem","year":"1989","journal-title":"J. Pediatr."},{"issue":"8","key":"10.1016\/j.gene.2018.10.002_bb0120","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1128\/IAI.00418-13","article-title":"Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs","volume":"81","author":"Konings","year":"2013","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.gene.2018.10.002_bb0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ppul.20092","article-title":"Longitudinal pulmonary status of cystic fibrosis children with meconium ileus","volume":"38","author":"Li","year":"2004","journal-title":"Pediatr. Pulmonol."},{"issue":"2","key":"10.1016\/j.gene.2018.10.002_bb0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00439-013-1363-7","article-title":"Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities","volume":"133","author":"Li","year":"2014","journal-title":"Hum. Genet."},{"key":"10.1016\/j.gene.2018.10.002_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2350-15-27","article-title":"Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study","volume":"15","author":"Marson","year":"2014","journal-title":"BMC Med. Genet."},{"issue":"2","key":"10.1016\/j.gene.2018.10.002_bb0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.gene.2018.10.002_bb0145","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2337\/diacare.24.7.1187","article-title":"Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy","volume":"24","author":"Moczulski","year":"2001","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.gene.2018.10.002_bb0150","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","article-title":"Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.gene.2018.10.002_bb0155","first-page":"L25","article-title":"The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability","volume":"295","author":"Moreau-Marquis","year":"2008","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"3","key":"10.1016\/j.gene.2018.10.002_bb0160","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1165\/rcmb.2008-0299OC","article-title":"Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells","volume":"41","author":"Moreau-Marquis","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.gene.2018.10.002_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35056009","article-title":"Modifier genes in mice and humans","volume":"2","author":"Nadeau","year":"2001","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.gene.2018.10.002_bb0170","doi-asserted-by":"crossref","first-page":"729S","DOI":"10.3945\/jn.110.130351","article-title":"HFE gene variants affect iron in the brain","volume":"141","author":"Nandar","year":"2011","journal-title":"J. Nutr."},{"issue":"5","key":"10.1016\/j.gene.2018.10.002_bb0175","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/hep.25856","article-title":"Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations","volume":"56","author":"Nelson","year":"2012","journal-title":"Hepatology"},{"issue":"Pt 6","key":"10.1016\/j.gene.2018.10.002_bb0180","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1099\/jmm.0.004416-0","article-title":"Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions","volume":"58","author":"O'May","year":"2009","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.gene.2018.10.002_bb0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1440-1843.2009.01649.x","article-title":"Population-based study of cystic fibrosis disease severity and haemochromatosis gene mutations","volume":"15","author":"Pratap","year":"2010","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.gene.2018.10.002_bb0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1378\/chest.121.1.48","article-title":"Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection","volume":"121","author":"Reid","year":"2002","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.gene.2018.10.002_bb0195","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1183\/09031936.00154006","article-title":"Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis","volume":"30","author":"Reid","year":"2007","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.gene.2018.10.002_bb0200","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jcf.2013.03.008","article-title":"Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis","volume":"12","author":"Reid","year":"2013","journal-title":"J. Cyst. Fibros."},{"issue":"1","key":"10.1016\/j.gene.2018.10.002_bb0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/gte.1998.2.85","article-title":"Is the hemochromatosis gene a modifier locus for cystic fibrosis?","volume":"2","author":"Rohlfs","year":"1998","journal-title":"Genet. Test."},{"issue":"6","key":"10.1016\/j.gene.2018.10.002_bb0210","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1478-3231.2012.02794.x","article-title":"Hepatitis C, porphyria cutanea tarda and liver iron: an update","volume":"32","author":"Ryan Caballes","year":"2012","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.gene.2018.10.002_bb0215","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/rccm.200512-1919OC","article-title":"Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data","volume":"174","author":"Schluchter","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.gene.2018.10.002_bb0220","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/ajh.22108","article-title":"Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR\/log ferritin index","volume":"86","author":"Skikne","year":"2011","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.gene.2018.10.002_bb0225","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1183\/09031936.00124012","article-title":"Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis","volume":"42","author":"Smith","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.gene.2018.10.002_bb0230","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ng.2221","article-title":"Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis","volume":"44","author":"Sun","year":"2012","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.gene.2018.10.002_bb0235","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood.V92.8.2934","article-title":"Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits","volume":"92","author":"Suominen","year":"1998","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.gene.2018.10.002_bb0240","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/ng.838","article-title":"Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2","volume":"43","author":"Wright","year":"2011","journal-title":"Nat. Genet."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918310266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918310266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T04:54:42Z","timestamp":1571979282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111918310266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":48,"alternative-id":["S0378111918310266"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2018.10.002","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutations in the HFE gene can be associated with increased lung disease severity in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}